[SSRI resistant depression. Supplementation with noradrenergic pharmaceuticals can be a good alternative].
2004 (Swedish)In: Läkartidningen, ISSN 0023-7205, Vol. 101, no 36, 2712-4 p.Article in journal (Refereed) Published
About five percent of the Swedes are treated with antidepressants, mostly SSRI:s. One third of those are non-responders. In that situation augmentation with a noradrenergic drug, such as reboxetine, can be a successful treatment strategy. This paper discusses clinical and scientific experiences of combinating SSRI:s and NRI:s.
Place, publisher, year, edition, pages
2004. Vol. 101, no 36, 2712-4 p.
IdentifiersURN: urn:nbn:se:umu:diva-43983PubMedID: 15455633OAI: oai:DiVA.org:umu-43983DiVA: diva2:417540